Last deal

Amount

Series B

Stage

26.01.2016

Date

3

all rounds

$65M

Total amount

General

About Company
Thesan Pharmaceuticals is a preclinical biopharmaceutical company developing innovative therapeutics for skin disorders.

Industry

Sector :

Subsector :

Also Known As

Thesan

founded date

01.01.2011

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

With a dedicated focus on dermatology, Thesan Pharmaceuticals is revolutionizing the field by developing New Chemical Entities that can offer substantial improvements in the treatment of skin disorders. Unlike many companies that simply reformulate existing drugs, Thesan's platform aims to provide novel and effective solutions for conditions like atopic dermatitis and acne. By prioritizing patient benefit, Thesan Pharmaceuticals is transforming the lives of those affected by skin disorders.
Contacts